Oppenheimer (OPY) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
4 May, 2026Executive summary
Revenue for Q1 2026 rose 21.0% year-over-year to $445.1 million, driven by higher investment banking, commissions, and advisory fees, despite a challenging geopolitical environment and market volatility.
Net loss attributable to shareholders was $20.6 million ($1.93 per share), compared to net income of $30.7 million ($2.93 per share) in Q1 2025, primarily due to a $70 million legal settlement and $22.3 million in stock appreciation rights expense.
Adjusted net income (Non-GAAP, excluding settlement and stock-based compensation) was $47.5 million, up 65.9% year-over-year.
Assets under management reached $54.1 billion and assets under administration were $139.8 billion, both up from the prior year.
Quarterly dividend increased by 11.1% to $0.20 per share, payable May 29, 2026.
Financial highlights
Compensation expenses increased 30.3% year-over-year to $296.0 million, mainly due to stock appreciation rights and higher incentive accruals.
Non-compensation expenses rose 77.2% to $176.1 million, largely due to the legal settlement.
Book value per share at quarter-end was $88.95; tangible book value per share was $72.28.
Adjusted basic EPS was $4.46, up from $2.74 in Q1 2025; reported basic EPS was $(1.93).
Effective tax rate for Q1 2026 was 23.8%, down from 25.9% in Q1 2025.
Outlook and guidance
Management expects to continue reporting non-GAAP measures excluding volatile stock appreciation rights expenses in future periods.
Focus remains on expanding wealth management and capital markets through hiring, acquisitions, and technology investments.
Continued investment in technology, compliance, and risk management, with ongoing review of office footprint and cost structure.
The company does not expect the legal settlement to materially impact liquidity or ongoing cash requirements.
Management remains focused on supporting clients amid ongoing market volatility and geopolitical uncertainty.
Latest events from Oppenheimer
- All proposals passed, directors re-elected, and record financial results achieved for 2025.OPY
AGM 20264 May 2026 - All proxy proposals are set for approval, with strong board governance and compensation oversight.OPY
Proxy Filing13 Mar 2026 - Annual meeting to vote on directors, auditors, executive pay, and charter changes, with all approvals expected.OPY
Proxy Filing2 Mar 2026 - Record 2024 results, leadership change, and all proposals approved amid market uncertainty.OPY
AGM 20253 Feb 2026 - Record 2025 earnings and revenue driven by robust Wealth Management and Capital Markets growth.OPY
Q4 202530 Jan 2026 - Annual meeting to elect directors, ratify auditors, and confirm CEO succession plan.OPY
Proxy Filing2 Dec 2025 - Q3 2025 revenue up 13.7% to $424.4M; net income down 11.4% on higher compensation costs.OPY
Q3 20253 Nov 2025 - Net income surged 111% year-over-year on strong revenue, record AUM, and robust trading.OPY
Q2 20251 Aug 2025 - Net income jumped 76.8% on record AUM, revenue, and improved segment performance.OPY
Q3 202413 Jun 2025